Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Mycothiol Processing Enzymes as Potential Anti-Mycobacterial Drug Targets

Anwar Jardine of the University of Cape Town in South Africa will attempt to disrupt the biosynthetic pathway of mycothiol, which is produced by the tuberculosis bacterium as a protective chemical compound. By targeting this metabolic pathway specific to mycobacteria, Jardine hopes to eliminate latent tuberculosis or make it more vulnerable to existing drugs.

More information about Create Drugs and Delivery Systems to Limit Drug Resistance (Round 1)